Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine by drops versus atomization for sedation during pediatric echocardiography
ChiCTR-TRC-14004104Phase 4Completed
- Sponsor
- Guangzhou Women and Children's Medical Centre
- Start
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexmedetomidine in Cardiovascular Malformation (CVM) (2 arms), sponsored by Guangzhou Women and Children's Medical Centre. Primary endpoints: University of Michigan Sedation Scale score and Aldrete recovery score. Started Jan 2014; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Cardiovascular Malformation (CVM)
Beyond the preview
Go deeper on ChiCTR-TRC-14004104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004104.